HEERLEN, THE NETHERLANDS--(Marketwire - Mar 14, 2013) - The Supervisory Board of Royal DSM
is pleased to announce that it will propose
to the Annual General Meeting of Shareholders on 3 May 2013 to appoint Mr.
Dimitri de Vreeze to the Managing Board of DSM with responsibility for
Materials Sciences clusters, with effect from 1 September 2013.
Mr. de Vreeze will succeed Mr. Nico Gerardu, who will be retiring from the
company after a long and rich career in DSM. Mr. Gerardu was appointed to
Managing Board in 2006, after holding several senior management positions
serving as Business Group Director of DSM Fine Chemicals and later DSM
The members of the Supervisory Board and Mr. Gerardu's colleagues on the
Managing Board would like to express their gratitude and thanks for his
leadership throughout his long career with DSM and for his contributions to
Dimitri de Vreeze (1967), a Dutch national, is at present Business Group
Director of DSM Resins. He has built a strong team while delivering real
progress in DSM Resins.
Mr. de Vreeze joined DSM in 1990 in Finance in DSM Fine Chemicals. He
subsequently moved to sales management and took on increasingly bigger
including that of Global Business Manager Sizing & Binders based in Italy.
2002 he became Business Director Composite Resins Europe, based in
Dimitri was Business Unit Director Coating Resins between 2005 and 2007 and
Business Unit Director NeoResins between 2007 and 2010.
Mr. de Vreeze studied Business Economics at the University of Groningen and
Postgraduate of the Chartered Controllers Program Maastricht.
DSM - Bright Science. Brighter Living.™
Royal DSM is a global science-based company active in health, nutrition and
materials. By connecting its unique competences in Life Sciences and
Sciences DSM is driving economic prosperity, environmental progress and
advances to create sustainable value for all stakeholders. DSM delivers
innovative solutions that nourish, protect and improve performance in
markets such as food and dietary supplements, personal care, feed,
pharmaceuticals, medical devices, automotive, paints, electrical and
electronics, life protection, alternative energy and bio-based materials.
23,500 employees deliver annual net sales of around EUR9 billion. The
listed on NYSE Euronext. More information can be found at www.dsm.com.
Dimitri de Vreeze-jpg:
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: DSM N.V. via Thomson Reuters ONE